167 related articles for article (PubMed ID: 5545459)
1. Infections with Providence bacilli. A clinical and bacteriologic study.
Solberg CO; Matsen JM
Am J Med; 1971 Feb; 50(2):241-6. PubMed ID: 5545459
[No Abstract] [Full Text] [Related]
2. Bacteriologic and epidemiologic characteristics of Enterobacter hafniae and Enterobacter liquefaciens.
Washington JA; Birk RJ; Ritts RE
J Infect Dis; 1971 Oct; 124(4):379-86. PubMed ID: 4335456
[No Abstract] [Full Text] [Related]
3. Serratia marcescens infections.
Acar JF
Infect Control; 1986 May; 7(5):273-8. PubMed ID: 3519496
[No Abstract] [Full Text] [Related]
4. Bacteremia due to serratia marcescens.
Wilfert JN; Barrett FF; Kass EH
N Engl J Med; 1968 Aug; 279(6):286-9. PubMed ID: 4873219
[No Abstract] [Full Text] [Related]
5. [Raoultella ornithinolytica in urinary tract infections. Clinical and microbiological study of a series of 4 oncologic patients].
García-Lozano T; Pascual Plá FJ; Aznar Oroval E
Med Clin (Barc); 2013 Aug; 141(3):138-9. PubMed ID: 23332629
[No Abstract] [Full Text] [Related]
6. Plasmid-mediated quinolone resistance genes in Enterobacteriaceae isolates associated with community and nosocomial urinary tract infection in East London, UK.
Amin AK; Wareham DW
Int J Antimicrob Agents; 2009 Nov; 34(5):490-1. PubMed ID: 19261447
[No Abstract] [Full Text] [Related]
7. Extended-Spectrum beta (β)-Lactamases and Antibiogram in Enterobacteriaceae from Clinical and Drinking Water Sources from Bahir Dar City, Ethiopia.
Abera B; Kibret M; Mulu W
PLoS One; 2016; 11(11):e0166519. PubMed ID: 27846254
[TBL] [Abstract][Full Text] [Related]
8. [Urinary infections by enterobacteriaceae resistent to antimicrobial agents].
Ales Reinlein JM; Vela Navarrete R; Fernández Puentes MC; Silva M
Rev Clin Esp; 1973 Aug; 130(4):295-300. PubMed ID: 4755593
[No Abstract] [Full Text] [Related]
9. Serratia marcescens as a postoperative pathogen.
Williams TW; Sailer JE; Viroslav J; Knight V; Glasgow N; Moreland N
Am J Surg; 1971 Jul; 122(1):64-9. PubMed ID: 4326385
[No Abstract] [Full Text] [Related]
10. A case of Raoultella ornithinolytica urinary tract infection in a pediatric patient.
Büyükcam A; Liste Ü; Bıçakçıgil A; Kara A; Sancak B
J Infect Chemother; 2019 Jun; 25(6):467-469. PubMed ID: 30683499
[TBL] [Abstract][Full Text] [Related]
11. Infections acquired in a pediatric hospital.
Gardner P; Carles DG
J Pediatr; 1972 Dec; 81(6):1205-10. PubMed ID: 4566041
[No Abstract] [Full Text] [Related]
12. [Isolation of Enterobacteriaceae from the pharyngeal mucosa in infantile diseases].
Mattiello A; Lanza GC
Ann Sclavo; 1972; 14(1):69-74. PubMed ID: 4592015
[No Abstract] [Full Text] [Related]
13. Enterobacteriaceae Sepsis Outcome Programme annual report, 2013.
Turnidge JD; Gottlieb T; Mitchell DH; Coombs GW; Daly DA; Bell JM;
Commun Dis Intell Q Rep; 2014 Dec; 38(4):E327-33. PubMed ID: 25631595
[TBL] [Abstract][Full Text] [Related]
14. Switching from CLSI to EUCAST XL susceptibility breakpoint: its implication in urinary tract infection in men.
Aguirre-Quiñonero A; Lecaroz Agara MC; Canut Blasco A
Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1813-1815. PubMed ID: 29936620
[No Abstract] [Full Text] [Related]
15. Fosfomycin: an oral agent for urinary infection caused by extended spectrum beta-lactamase producing organisms.
Hutley EJ; Chand MA; Hounsome G; Kelsey MC
J Infect; 2010 Apr; 60(4):308-9. PubMed ID: 20114062
[No Abstract] [Full Text] [Related]
16. Outcomes of Fosfomycin Use in Ceftriaxone-Resistant Enterobacteriaceae Urinary Tract Infection in the Elderly.
Quek WM; Teng CB; Tan YZ; Chong K; Lye DC; Ng TM
Int J Antimicrob Agents; 2019 Feb; 53(2):195-196. PubMed ID: 30722963
[No Abstract] [Full Text] [Related]
17. [Effectiveness of using aminoglycoside antibiotics in septicemia and urinary tract infections in newborn infants].
Sentsova TB; Bombardirova EP; Mamedkulieva DT; Bekmukhambetova ER
Antibiot Khimioter; 1990 Oct; 35(10):50-2. PubMed ID: 2126174
[TBL] [Abstract][Full Text] [Related]
18. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
Pang F; Jia XQ; Zhao QG; Zhang Y
Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
[TBL] [Abstract][Full Text] [Related]
19. Fosfomycin activity versus carbapenem-resistant Enterobacteriaceae and vancomycin-resistant Enterococcus, Detroit, 2008-10.
Pogue JM; Marchaim D; Abreu-Lanfranco O; Sunkara B; Mynatt RP; Zhao JJ; Bheemreddy S; Hayakawa K; Martin ET; Dhar S; Kaye KS; Lephart PR
J Antibiot (Tokyo); 2013 Oct; 66(10):625-7. PubMed ID: 23715037
[No Abstract] [Full Text] [Related]
20. [Ecological behavior of Klebsielleae].
Fritsche D; Spieckermann C; Dostal C
Med Klin; 1972 Sep; 67(39):1246-9. PubMed ID: 4565309
[No Abstract] [Full Text] [Related]
[Next] [New Search]
